National Health Investors (NHI) Price to Earnings (2009 - 2026)

National Health Investors (NHI) has reported Price to Earnings for 16 consecutive years, with 66.28 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Earnings fell 23.58% year-over-year to 66.28; the trailing twelve-month figure through Jun 2026 stood at 22.12 (down 1.42% YoY), and the FY2025 full-year result was 25.98, up 13.14% from the prior year.
• Price to Earnings slipped to 66.28 in Q2 2026 per NHI's latest filing, from 97.59 in the prior quarter.
• Across five years, Price to Earnings topped out at 1216.19 in Q4 2022 and bottomed at 57.23 in Q2 2023.
• Historically, Price to Earnings has averaged 153.88 across 5 years, with a median of 86.73 in 2025.
• The sharpest annual moves came in 2023 and 2024: Price to Earnings slumped 93.78% in 2023, then soared 68.35% in 2024.
• Over 5 years, Price to Earnings stood at 1216.19 in 2022, then plunged by 93.78% to 75.7 in 2023, then decreased by 3.21% to 73.27 in 2024, then jumped by 32.1% to 96.79 in 2025, then tumbled by 31.52% to 66.28 in 2026.
• According to Business Quant data, Price to Earnings over the past three periods registered 66.28, 97.59, and 96.79 for Q2 2026, Q1 2026, and Q4 2025 respectively.